Regulations

(12963734/iStock via Getty Images Plus)

FDA COVID-19 news roundup this week

By Jenni Spinner

The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.

(DonkeyWorx/iStock via Getty Images Plus)

Latest FDA updates on COVID-19 battle

By Jenni Spinner

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

(peterschreiber.media/iStock via Getty Images Plus)

FDA okays first COVID-19 treatment

By Jenni Spinner

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

(olegback/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.

(Egor Shabanov/iStock via Getty Images Plus)

FDA COVID-19 response roundup

By Jenni Spinner

As the pandemic maintains its hold, the US agency continues to issue advice and take action related to testing, treatment and information on the virus.

(Vacclav/iStock via Getty Images Plus)

Trump and COVID-19: treatments to date

By Jenni Spinner

With the virus reaching the Oval Office, the presidential diagnosis is shining a spotlight on some of the drugs reportedly administered to the POTUS.

(ClaudioVentrella/iStock via Getty Images Plus)

Breaking FDA COVID-19 news

By Jenni Spinner

The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.

(Frantab/iStock via Getty Images Plus)

PRA: get ready for the RACE Act

By Jenni Spinner

Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.

(bennymarty/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.

(gilz/iStock via Getty Images Plus)

Weekly FDA COVID-19 updates and actions

By Jenni Spinner

The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.

Follow us

Product Innovations

Transforming Clinical Development

Transforming Clinical Development

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...